Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| scPharmaceuticals Inc | SCPH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 4.50 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.50 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 4.25 - 12.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 4.50 | USD |
scPharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 162.24M | 36.05M | - | 13.59M | -54.81M | -1.52 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
scPharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SCPH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.42 | 4.79 | 4.25 | 4.54 | 136,352 | 0.08 | 1.81% |
| 1 Month | 5.13 | 5.33 | 4.25 | 4.82 | 168,598 | -0.63 | -12.28% |
| 3 Months | 4.95 | 6.54 | 4.25 | 5.31 | 222,296 | -0.45 | -9.09% |
| 6 Months | 5.67 | 6.71 | 4.25 | 5.41 | 293,902 | -1.17 | -20.63% |
| 1 Year | 10.08 | 12.75 | 4.25 | 7.47 | 316,613 | -5.58 | -55.36% |
| 3 Years | 6.80 | 12.75 | 3.48 | 7.05 | 229,968 | -2.30 | -33.82% |
| 5 Years | 3.05 | 12.75 | 2.78 | 6.97 | 172,355 | 1.45 | 47.54% |
scPharmaceuticals Description
| scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's lead product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure. |
